Cue Biopharma Inc (CUE)
1.50
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
1.51
+0.01
(+0.67%)
After-Hours: 07:10
Cue Biopharma Cash and Short Term Investments (Quarterly): 30.03M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 30.03M |
| March 31, 2024 | 41.03M |
| December 31, 2023 | 48.51M |
| September 30, 2023 | 54.69M |
| June 30, 2023 | 57.89M |
| March 31, 2023 | 66.20M |
| December 31, 2022 | 76.29M |
| September 30, 2022 | 59.18M |
| June 30, 2022 | 66.13M |
| March 31, 2022 | 67.93M |
| December 31, 2021 | 64.37M |
| September 30, 2021 | 67.63M |
| June 30, 2021 | 73.92M |
| March 31, 2021 | 73.26M |
| December 31, 2020 | 84.87M |
| Date | Value |
|---|---|
| September 30, 2020 | 91.80M |
| June 30, 2020 | 84.93M |
| March 31, 2020 | 48.73M |
| December 31, 2019 | 59.41M |
| September 30, 2019 | 31.38M |
| June 30, 2019 | 28.26M |
| March 31, 2019 | 30.88M |
| December 31, 2018 | 39.21M |
| September 30, 2018 | 39.18M |
| June 30, 2018 | 45.74M |
| March 31, 2018 | 53.15M |
| December 31, 2017 | 63.53M |
| September 30, 2017 | 3.450M |
| June 30, 2017 | 7.357M |
| December 31, 2016 | 14.98M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
30.03M
Minimum
Jun 2024
91.80M
Maximum
Sep 2020
64.04M
Average
66.13M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 930.44M |
| Arbutus Biopharma Corp | 127.79M |
| GlycoMimetics Inc | 22.39M |
| FibroGen Inc | 140.71M |
| Cidara Therapeutics Inc | 127.39M |